Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Autophagy01:27

Autophagy

5.8K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.8K
Feedback Inhibition00:46

Feedback Inhibition

57.1K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Enzyme Inhibition01:30

Enzyme Inhibition

91.9K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.9K
What is Natural Selection?01:32

What is Natural Selection?

128.1K
Natural selection is an evolutionary process in which individuals with survival-promoting traits reproduce at higher rates. These favorable traits become more common within a population or species. Naturally selected traits initially arise via random genetic mutations. In order for selection to occur, there must be variation within a population, the trait controlling the variation must be heritable, and there must be an evolutionary advantage for variation in the trait.
128.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

6.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Correction to "Novel Small Molecule-Derived, Highly Selective Substrates for Fibroblast Activation Protein (FAP)".

ACS medicinal chemistry letters·2026
Same author

Stepwise Differentiation of Mouse Embryonic Stem Cells Into Murine Blood Vessel Organoids With Endothelial Lineage Tracing for Quality Control.

Bio-protocol·2026
Same author

Development and reliability testing of BRANT-MERQS-2A: A quality assessment tool for medication review type 2a reports.

International journal of clinical pharmacy·2026
Same author

The INSPIRE doctoral network in safety pharmacology - Looking back and ahead.

Journal of pharmacological and toxicological methods·2026
Same author

Binding Mechanism of UAMC-1110 to Fibroblast Activation Protein.

Journal of chemical information and modeling·2026
Same author

Identification of small-molecule autophagy activators via GFP-LC3 high-throughput screening and a cargo-based autophagy flux and processing assay.

European journal of pharmacology·2026

Video Experimental Relacionado

Updated: Jan 28, 2026

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.4K

Inhibidores vectorizados de ULK1/2 y VPS34 para la inhibición selectiva del tejido de la autofagia en oncología

Lorenzo Cianni1, Kathryn Jacobs2,3, Sergei Grintsevich1

  • 1Laboratory of Medicinal Chemistry (UAMC), Department of Pharmaceutical Sciences, University of Antwerp, 2610 Wilrijk, Belgium.

Journal of medicinal chemistry
|January 26, 2026
PubMed
Resumen

Los investigadores desarrollaron inhibidores novedosos de la autofagia dirigidos a tumores para bloquear selectivamente los mecanismos de supervivencia de las células cancerosas. Estos compuestos son prometedores para la terapia del cáncer al inhibir la autofagia específicamente en los tumores, respetando los tejidos sanos.

Palabras clave:
inhibidores de la autofagiaterapia contra el cáncerULK1/2VPS34medicina de precisiónoncología

Más Videos Relacionados

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

1.5K
Activating Autophagy by Aerobic Exercise in Mice
08:44

Activating Autophagy by Aerobic Exercise in Mice

Published on: February 3, 2017

12.7K

Videos de Experimentos Relacionados

Last Updated: Jan 28, 2026

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.4K
Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

1.5K
Activating Autophagy by Aerobic Exercise in Mice
08:44

Activating Autophagy by Aerobic Exercise in Mice

Published on: February 3, 2017

12.7K

Área de la Ciencia:

  • Biología Molecular
  • Biología Celular
  • Investigación sobre el Cáncer

Sus antecedentes:

  • La autofagia es un proceso celular clave crucial para la supervivencia y la homeostasis.
  • Los tumores explotan la autofagia para la plasticidad, la adaptación y la resistencia a la terapia, lo que la convierte en un objetivo terapéutico.
  • La inhibición selectiva de la autofagia en los tumores es esencial debido a su papel vital en los tejidos sanos.

Objetivo del estudio:

  • Diseñar y validar inhibidores de la autofagia dirigidos a tumores.
  • Desarrollar compuestos que inhiban selectivamente los factores de iniciación de la autofagia (ULK1/2 y VPS34) en células cancerosas.
  • Explorar estrategias terapéuticas novedosas para la oncología.

Principales métodos:

  • Diseño de inhibidores de factores de iniciación de la autofagia (ULK1/2 y VPS34) con vectores dirigidos a tumores.
  • Se utilizó un andamio inhibidor de ULK1/2 de baja nanomolar combinado con un péptido de direccionamiento de secuencia RGR.
  • Se validaron los compuestos a través de modelos preclínicos in vitro, in cellulo e in vivo.

Principales resultados:

  • Se desarrollaron inhibidores prometedores de la autofagia dirigidos a tumores.
  • Se demostró la actividad selectiva de los compuestos en modelos preclínicos.
  • Se mostró la eficacia conservada de los inhibidores en la focalización de la autofagia específica del tumor.

Conclusiones:

  • Los compuestos desarrollados son los primeros ejemplos de inhibidores de la autofagia dirigidos a tumores.
  • Estos inhibidores ofrecen un nuevo enfoque para la modulación tisular específica de la autofagia.
  • Existen aplicaciones potenciales en oncología y otros campos que requieren la regulación de la autofagia.